01
Marketing support studies
Post-approval and Phase IV studies that generate real-world evidence to strengthen market positioning and prescriber confidence.
Overview
Voxtur Clinical Research provides Clinical Trial Management Services for pharmaceutical and biopharmaceutical companies, supporting clinical studies from feasibility and protocol planning through site selection, study activation, trial conduct, close-out and final reporting. Our clinical research teams coordinate study activities, documentation, investigators and sites to maintain consistent oversight throughout the trial.
With more than 20 years of scientific and operational experience, including experience in oncology, Voxtur supports complex exploratory and confirmatory clinical trials. Study management follows applicable ICH-GCP, US FDA, EMA and TGA requirements, with a focus on quality, regulatory compliance, clear documentation and reliable study execution.
Capabilities
Post-approval and Phase IV studies that generate real-world evidence to strengthen market positioning and prescriber confidence.
Pivotal, confirmatory trials designed to meet the evidentiary requirements of regulated-market submissions.
Early exploratory studies that establish clinical signal, dose range and clear go/no-go decisions before larger investment.
Protocols, investigator brochures, clinical study reports and regulatory narratives authored to ICH E3 standards.
End-to-end operational, regulatory and statistical support for clinician- and academic-led research.
Full-lifecycle delivery across every trial phase and therapeutic area, led by oncology.
Why Voxtur
One team owns planning, conduct and reporting across the full lifecycle.
Proven experience designing and running complex oncology protocols.
ICH-GCP, USFDA, EMA and TGA adherence built into every process.
System-driven execution that protects timelines without compromising data.
Explore More
Speak with our team about how clinical trial management can support your molecule and target markets.